Role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats

American Journal of Clinical Nutrition

Volumn 68, Issue 6 SUPPL., 1998, Pages

  Arjmandi, Bahram H ^a   Getlinger, Mary J ^b   Goyal, Noopur V ^b   Alekel, Lee ^b   Hasler, Clare M ^b   Juma, Shanil ^b   Drum, Melinda L ^b   Hollis, Bruce W ^b   Kukreja, Subhash C ^b  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b NONE

Author keywords

Bone density; Casein; Isoflavones; Messenger RNA; Osteoporosis; Ovariectomy; Rats; Soy protein

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; CALCIFEDIOL; CALCITRIOL; CALCIUM ION; CASEIN; ESTRADIOL; HYDROXYPROLINE; ISOFLAVONE; MESSENGER RNA; SEX HORMONE; SOMATOMEDIN C; SOYBEAN PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; CONTROLLED STUDY; CORTICAL BONE; FEMALE; FEMUR; HORMONE DEFICIENCY; LUMBAR VERTEBRA; NONHUMAN; OSTEOPOROSIS; OVARIECTOMY; PROTEIN INTAKE; RAT;

ANIMALIA; GLYCINE MAX;

EID: 0031770982     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/68.6.1358S     Document Type: Article

References (43)

1. Avioli LV. Significance of osteoporosis: a growing international health care problem. Calcif Tissue Int 1991:49(suppl):S11-4.
2. Bonnick SL. AMWA position statement on osteoporosis. J A Med Womens Assoc 1990;45:75-9.
3. Mundy GR. Visions for the future in osteoporosis research. Osteoporos Int 1993;2(suppl):S29-S34.
4. Tolstoi LG, Levin RM. Osteoporosis: the treatment controversy. Nutr Today 1992;27:6-12.
5. Lindsay R. Prevention and treatment of osteoporosis. Lancet 1993;341:801-5.
6. Raisz LG. Bone cell biology: new approaches and unanswered questions. J Bone Miner Res 1993;8(suppl 2):S457-65.
7. Gallagher JC. The pathogenesis of osteoporosis. Bone Miner 1990;9:215-27.
8. Eriksen EF, Axellrod DW, Melsen F. Bone histomorphometry. New York: Raven Press, 1994.
9. Hunt SM, Groff JL. Advanced nutrition and human metabolism. New York: West Publishing Co, 1990.
10. Teitelbaum SL. Skeletal growth and development. In: Primer of metabolic bone diseases and disorders of mineral metabolism. New York: Raven Press, 1991:7-11.
11. Watts NB, Harris ST, Genant HK, et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990;323:73-9.
12. Turner CH. Toward a cure for osteoporosis: reversal of excessive bone fragility. Osteoporos Int 1991;2:12-19.
13. Grisanti JM. Some new views on preventing osteoporosis. Contemp Ob/Gyn 1989;33:60-78.
14. Wardlaw GM. Putting osteoporosis in perspective. J Am Diet Assoc 1993;93:1000-6.
15. Kalu DN, Masoro EJ, Byung PY, Hardin RR, Hollis BW. Modulation of age-related hyperparathyroidism and senile bone loss in Fischer rats by soy protein and food restriction. Endocrinology 1988;122:1847-54.
16. Omi N, Aoi S, Murata K, Ezawa I. Evaluation of the effect of soybean milk and soybean milk peptide on bone metabolism in the rat model with ovariectomized osteoporosis. J Nutr Sci 1994; 40:201-21.
17. Arjmandi BH, Alekel L, Hollis BW, et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis. J Nutr 1996;126:161-7.
18. Goyal N, Getlinger MJ, Sun P, et al. Effect of soy protein, with and without isoflavonoids, on bone in ovariectomized rats. J Bone Miner Res 1995;10(suppl 1):S453 (abstr).
19. Petilli M, Fiorelli G, Benvenuti S, Frediani U. Interactions between ipriflavone and the estrogen receptor. Calcif Tissue Int 1995;56:160-5.
20. Benvenuti S, Petilli M, Frediani U, Tanini A. Binding and bioeffects of irpriflavone on a human preosteoclastic cell line. Biochem Biophys Res Commun 1994;201:1084-9.
21. Civitelli R, Abbasi-Jarhomi SH, Halstead LR, Dimarogonas A. Ipriflavone improves bone density and biomechanical properties of adult male rat bones. Calcif Tissue Int 1995;56:215-9.
22. Valente M, Bufalino L, Castiglione GN, D'Angelo R. Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass. Calcif Tissue Int 1994;54:377-80.
23. Kalu DN, Liu CC, Salerno E, Hollis B, Echon R, Ray M. Skeletal response of ovariectomized rats to low and high doses of 17β-estradiol. Bone Miner 1991;14:175-87.
24. Taussky HH, Shorr E. A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem 1953;202:675-85.
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1986;162:156-9.
26. Barengolts EI, Kouznetsova T, Segalene A, Lanthon P, Odvina C, Kukreja SC, Unterman TG. Effects of progesterone on serum levels of IGF-I and on femur IGF-I mRNA in ovariectomized rats. J Bone Miner Res 1996;11:1406-12.
27. Roberts CT Jr, Lasky SR, Lowe WL Jr, Seaman WT, Leroith D. Molecular cloning of rat insulin-like growth factor 1 complimentary deoxyribonucleic acid: Differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues. Mol Endocrinol 1987;1:243-8.
28. Unterman TG, Jentel JJ, Oehler D, Lacson RG, Hofert JF. Effects of glucocorticoids on circulating levels and hepatic expression of insulin-like growth factor-I binding proteins and IGF-I in the adrenalectomized streptozotocin-diabetic rat. Endocrinology 1993;133:2531-9.
29. Ney DM, Yang H, Smith S, Unterman TG. High-calorie total parenteral nutrition reduces hepatic insulin-like growth factor-I mRNA and alters serum levels of insulin-like growth factor binding protein-1, -3, -5, and -6 in the rat. Metabolism 1995;44:152-60.
30. Hollis BW. Assay of circulating 1,25 dihydroxy vitamin D involving a novel single-cartridge extraction and purification procedure. Clin Chem 1986;32:2060-3.
31. 125I-labeled tracer. Clin Chem 1993;39:529-33.
32. Kivirikko KI, Laitinen O, Prockop DJ. Modification of a specific assay for hydroxyproline in urine. Anal Biochem 1967;19:249-55.
33. Daniel WE. Biostatistics: a foundation for analysis in the health sciences. New York: John Wiley & Sons, 1991.
34. Kalu DN, Arjmandi BH, Liu CC, Salih MA, Birnbaum RS. Effects of ovariectomy and estrogen on the serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3. Bone Miner 1994;24:135-48.
35. Kanis JA. Estrogens, the menopause, and osteoporosis. Bone 1996;19:185S-90S.
36. Gallaher DD, Gallaher CM, An Z, Hoffman RM. Soy protein isolates and genistein: Effects on initiation, promotion, and progression of colon cancer. Am J Clin Nutr 1998;68(suppl):1524S (abstr).
37. Jayo MJ, Anthony MS, Register TC, Rankin SE, Vest T, Clarkson TB. Dietary soy isoflavones and bone loss: a study in ovariectomized monkeys. J Bone Miner Res 1996;11:5228 (abstr).
38. Anderson JJ, Garner SC. The effects of phytoestrogens on bone. Nutr Res 1997;17:1617-32.
39. Fanti O, Faugere MC, Gang Z, Schmidt J, Cohen D, Malluche HH. Systematic administration of genistein partially prevents bone loss in ovariectomized rats in a nonestrogen-like mechanism. Am J Clin Nutr 1998;68(suppl):1517S (abstr).
40. Kalu DN, Salerno E, Liu CC, et al. A comparative study of the action of tamoxifen, estrogen and progesterone in ovariectomized rat. Bone Miner 1991;15:109-24.
41. Ettlinger B, Golditch IM, Friedman G. Gynecologic consequences of long-term unopposed estrogen replacement therapy. Maturitas 1988;10:271-82.
42. Andreassen TT, Jorgensen PH, Flyvbjerg A, Orskov H, Oxlund H. Growth hormone stimulates bone formation and strength of cortical bone in aged rats. J Bone Miner Res 1995;10:1057-67.
43. Wright NM, Renault J, Hollis B, Bell NH, Key LL. Effect of growth hormone on bone: bone mineral density, trabecular bone volume, and alkaline phosphatase improve or are restored in the dwarf rat treated with growth hormone. J Bone Miner Res 1995;10:127-31.